Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$708.51
+2.6%
$602.45
$437.37
$714.30
$211.97B1.322.37 million shs3.97 million shs
Morgan Stanley stock logo
MS
Morgan Stanley
$141.08
+0.3%
$127.20
$90.94
$142.03
$225.71B1.296.66 million shs8.03 million shs
Oracle Corporation stock logo
ORCL
Oracle
$218.98
+4.2%
$170.34
$118.86
$228.22
$590.53B1.329.93 million shs31.82 million shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$405.83
-0.6%
$409.41
$385.46
$627.88
$154.12B0.781.95 million shs3.92 million shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
+2.57%+9.46%+18.11%+29.17%+56.64%
Morgan Stanley stock logo
MS
Morgan Stanley
+0.31%+5.25%+10.33%+21.81%+45.16%
Oracle Corporation stock logo
ORCL
Oracle
+4.20%+5.75%+32.69%+54.15%+55.08%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
-0.45%+1.39%+0.85%-15.89%-26.61%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
4.91 of 5 stars
2.23.04.23.02.23.33.8
Morgan Stanley stock logo
MS
Morgan Stanley
4.679 of 5 stars
2.23.04.22.42.72.52.5
Oracle Corporation stock logo
ORCL
Oracle
4.4931 of 5 stars
2.43.01.73.04.03.31.3
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
4.9934 of 5 stars
4.43.02.54.13.32.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.32
Hold$595.67-15.93% Downside
Morgan Stanley stock logo
MS
Morgan Stanley
2.41
Hold$133.62-5.29% Downside
Oracle Corporation stock logo
ORCL
Oracle
2.79
Moderate Buy$200.26-8.55% Downside
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.80
Moderate Buy$604.0548.84% Upside

Current Analyst Ratings Breakdown

Latest TMO, GS, MS, and ORCL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/30/2025
Oracle Corporation stock logo
ORCL
Oracle
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$180.00 ➝ $250.00
6/25/2025
Oracle Corporation stock logo
ORCL
Oracle
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$225.00 ➝ $250.00
6/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$475.00 ➝ $450.00
6/23/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$570.00 ➝ $592.00
6/18/2025
Oracle Corporation stock logo
ORCL
Oracle
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
6/18/2025
Oracle Corporation stock logo
ORCL
Oracle
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
6/18/2025
Oracle Corporation stock logo
ORCL
Oracle
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
6/18/2025
Oracle Corporation stock logo
ORCL
Oracle
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
6/18/2025
Oracle Corporation stock logo
ORCL
Oracle
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingStrong-Buy ➝ Strong-Buy
6/18/2025
Morgan Stanley stock logo
MS
Morgan Stanley
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$125.00 ➝ $130.00
6/18/2025
Oracle Corporation stock logo
ORCL
Oracle
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$220.00 ➝ $250.00
(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$126.85B1.71$55.05 per share12.87$350.27 per share2.02
Morgan Stanley stock logo
MS
Morgan Stanley
$107.29B2.11$11.55 per share12.22$59.39 per share2.38
Oracle Corporation stock logo
ORCL
Oracle
$57.40B10.72$6.97 per share31.44$7.47 per share29.31
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$42.88B3.57$29.86 per share13.59$129.54 per share3.13
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$14.28B$43.0916.4413.610.9411.86%13.76%0.87%7/16/2025 (Estimated)
Morgan Stanley stock logo
MS
Morgan Stanley
$13.39B$8.5216.5614.961.2912.98%14.98%1.15%7/16/2025 (Estimated)
Oracle Corporation stock logo
ORCL
Oracle
$12.44B$4.3450.4639.033.1521.68%87.34%8.94%9/8/2025 (Estimated)
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.34B$17.0523.8015.882.1715.19%17.15%8.47%7/23/2025 (Estimated)

Latest TMO, GS, MS, and ORCL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/23/2025Q2 2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.22N/AN/AN/A$10.68 billionN/A
7/16/2025Q2 2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$9.82N/AN/AN/A$13.53 billionN/A
7/16/2025Q2 2025
Morgan Stanley stock logo
MS
Morgan Stanley
$2.01N/AN/AN/A$16.15 billionN/A
6/11/2025Q4 2025
Oracle Corporation stock logo
ORCL
Oracle
$1.64$1.70+$0.06$1.19$15.58 billion$15.90 billion
4/23/2025Q1 2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.10$5.15+$0.05$3.98$10.23 billion$10.36 billion
4/14/2025Q1 2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$12.57$14.12+$1.55$14.12$14.99 billion$15.06 billion
4/11/2025Q1 2025
Morgan Stanley stock logo
MS
Morgan Stanley
$2.21$2.60+$0.39$2.60$16.81 billion$17.74 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$12.001.69%N/A27.85%13 Years
Morgan Stanley stock logo
MS
Morgan Stanley
$3.702.62%N/A43.43%12 Years
Oracle Corporation stock logo
ORCL
Oracle
$2.000.91%N/A46.08%1 Years
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.720.42%N/A10.09%8 Years

Latest TMO, GS, MS, and ORCL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/12/2025
Oracle Corporation stock logo
ORCL
Oracle
quarterly$0.501%7/10/20257/10/20257/24/2025
5/21/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.430.43%6/13/20256/13/20257/15/2025
4/15/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
quarterly$3.002.3%5/30/20255/30/20256/27/2025
4/11/2025
Morgan Stanley stock logo
MS
Morgan Stanley
quarterly$0.92503.48%4/30/20254/30/20255/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.41
0.68
0.68
Morgan Stanley stock logo
MS
Morgan Stanley
3.11
0.78
0.78
Oracle Corporation stock logo
ORCL
Oracle
4.07
0.75
0.75
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.64
1.77
1.38

Institutional Ownership

CompanyInstitutional Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
Morgan Stanley stock logo
MS
Morgan Stanley
84.19%
Oracle Corporation stock logo
ORCL
Oracle
42.44%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
89.23%

Insider Ownership

CompanyInsider Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.55%
Morgan Stanley stock logo
MS
Morgan Stanley
0.19%
Oracle Corporation stock logo
ORCL
Oracle
42.20%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
46,500306.84 million305.15 millionOptionable
Morgan Stanley stock logo
MS
Morgan Stanley
80,0001.60 billion1.60 billionOptionable
Oracle Corporation stock logo
ORCL
Oracle
162,0002.81 billion1.62 billionOptionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
125,000377.49 million376.25 millionOptionable

Recent News About These Companies

Biotech Stocks To Consider - June 30th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
The Goldman Sachs Group stock logo

The Goldman Sachs Group NYSE:GS

$708.51 +17.70 (+2.56%)
As of 06/30/2025 03:58 PM Eastern

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.

Morgan Stanley stock logo

Morgan Stanley NYSE:MS

$141.08 +0.39 (+0.28%)
As of 06/30/2025 03:58 PM Eastern

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; foreign exchange and commodities; corporate and commercial real estate loans, commercial mortgage and secured lending facilities, and financing for sales and trading customers, and asset-backed and mortgage lending; and wealth management services, investment, and research services. The Wealth Management segment offers financial advisor-led brokerage, custody, administrative, and investment advisory services; self-directed brokerage services; financial and wealth planning services; workplace services, including stock plan administration; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services to individual investors and small to medium-sized businesses and institutions. The Investment Management segment provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals through institutional and intermediary channels. The company was founded in 1924 and is headquartered in New York, New York.

Oracle stock logo

Oracle NYSE:ORCL

$218.98 +8.74 (+4.16%)
As of 06/30/2025 03:58 PM Eastern

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing. The company also offers cloud-based industry solutions for various industries; Oracle application licenses; and Oracle license support services. In addition, it provides cloud and license business' infrastructure technologies, such as the Oracle Database and MySQL Database; Java, a software development language; and middleware, including development tools and others. The company's cloud and license business' infrastructure technologies also comprise cloud-based compute, storage, and networking capabilities; and Oracle autonomous database, MySQL HeatWave, Internet-of-Things, digital assistant, and blockchain. Further, it provides hardware products and other hardware-related software offerings, including Oracle engineered systems, enterprise servers, storage solutions, industry-specific hardware, virtualization software, operating systems, management software, and related hardware services; and consulting and customer services. The company markets and sells its cloud, license, hardware, support, and services offerings directly to businesses in various industries, government agencies, and educational institutions, as well as through indirect channels. The company has a collaboration with Amdocs Limited to empower customers on their journey towards cloud and digital adoption. Oracle Corporation was founded in 1977 and is headquartered in Austin, Texas.

Thermo Fisher Scientific stock logo

Thermo Fisher Scientific NYSE:TMO

$405.83 -2.45 (-0.60%)
As of 06/30/2025 03:58 PM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.